Novartis said on Sunday that Kisqali helped women with advanced breast cancer af...
FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo
Kisqali plus the hormone therapy fulvestrant, when compared to fulvestrant alone, demonstrated a significant improvement in survival with a 28% reduction in risk of death, Novartis said at the European Society for Medical Oncology meeting in Barcelona. The Basel-based firm said this year that Kisqali also boosted survival for women before menopause with hormone receptor positive, human epidermal growth factor receptor-2 negative advanced or metastatic breast cancer.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Bristol-Myers immunotherapy combo outperforms chemo in lung cancer survival: studyAbout 40% of patients who received a combination of Bristol-Myers Squibb Co&039...
Baca lebih lajut »
H&M Canada Taps Three Canadian Artists for Limited Edition BCA ShirtsH&M Canada has teamed up with three Canadian artists to create a limited edition collection of t-shirts in support of Toronto-based charity, Rethink Breast Cancer.
Baca lebih lajut »
A viral fake news story linked trans health care to “thousands” of deathsHormone blockers used by some transgender people have multiple uses, including treating prostate cancer in terminally ill patients.
Baca lebih lajut »
Actress Katie Stevens Has the Most Common Benign Breast Tumor — Here Are the SignsActress Katie Stevens opened up on Instagram about a fibroadenoma. Here's what one doctor said about this common type of benign breast tumor.
Baca lebih lajut »
What are Dank Vapes? CDC links these products to vaping illnesses'Dank Vapes' were reportedly used by many patients in Illinois and Wisconsin.
Baca lebih lajut »
Legendary Mexican crooner José José dies from cancerLegendary Mexican crooner known as the 'Prince of Song' has died from pancreatic cancer.
Baca lebih lajut »